Demographic diversity of participants in Pfizer sponsored clinical trials in the United States

The approval of new medicinal agents requires robust efficacy and safety clinical trial data demonstrated to be applicable to population subgroups. Limited data have previously been reported by drug sponsors on the topic of clinical trial diversity. In order to establish a baseline of diversity in o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Contemporary clinical trials 2021-07, Vol.106, p.106421-106421, Article 106421
Hauptverfasser:	Rottas, Melinda, Thadeio, Peter, Simons, Rachel, Houck, Raven, Gruben, David, Keller, David, Scholfield, David, Soma, Koshika, Corrigan, Brian, Schettino, Annette, McCann, Patrick J., Hellio, Marie-Pierre, Natarajan, Kannan, Goodwin, Rob, Sewards, Judy, Honig, Peter, MacKenzie, Rod
Format:	Artikel
Sprache:	eng
Schlagworte:	African Americans Clinical trials Clinical Trials as Topic Diversity Drug Industry Ethnicity Female Hawaii Hispanic or Latino Humans Pfizer Race Representation United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!